BC
AMGN icon

Burleson & Co’s Amgen AMGN Stock Holding History

Burleson & Co’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$513K Sell
1,953
-1,298
-40% -$348K 0.13% 99
2022
Q3 		$733K Sell
3,251
-2
-0.1% -$485 0.16% 88
2022
Q2 		$792K Buy
3,253
+7
+0.2% +$1.72K 0.17% 81
2022
Q1 		$785K Sell
3,246
-40
-1% -$9.19K 0.13% 89
2021
Q4 		$739K Buy
3,286
+2
+0.1% +$422 0.11% 88
2021
Q3 		$698K Sell
3,284
-3
-0.1% -$690 0.1% 82
2021
Q2 		$801K Buy
3,287
+45
+1% +$11.1K 0.12% 81
2021
Q1 		$807K Sell
3,242
-14,130
-81% -$3.37M 0.13% 78
2020
Q4 		$3.99M Sell
17,372
-7,436
-30% -$1.71M 0.69% 30
2020
Q3 		$5.75M Sell
24,808
-7,869
-24% -$1.95M 1.09% 21
2020
Q2 		$7.87M Buy
32,677
+4,293
+15% +$979K 1.72% 15
2020
Q1 		$6.67M Buy
28,384
+3,923
+16% +$857K 1.74% 15
2019
Q4 		$5.79M Sell
24,461
-311
-1% -$68.6K 1.62% 15
2019
Q3 		$5.04M Buy
24,772
+234
+1% +$44.9K 1.76% 18
2019
Q2 		$4.56M Buy
24,538
+8,582
+54% +$1.54M 1.92% 16
2019
Q1 		$2.83M Buy
15,956
+9,597
+151% +$1.83M 1.2% 21
2018
Q4 		$1.18M Buy
6,359
+4,645
+271% +$906K 0.61% 45
2018
Q3 		$334K Buy
+1,714
New +$338K 0.19% 82

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Burleson & Co's AMGN Position: Q4 2022 in Review

Burleson & Co reduced its Amgen (AMGN) stake by 40% in Q4 2022, selling an estimated $348K and leaving 1,953 shares worth $513K. The position accounts for 0.13% of the portfolio, ranked #99.

Burleson & Co first reported a position in AMGN in Q3 2018 and has held it in 18 quarters since. The position peaked at $7.87M in Q2 2020. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Burleson & Co held 1,953 shares of Amgen worth $513K as of Q4 2022.
  • Burleson & Co sold 1,298 Amgen shares in Q4 2022, an estimated $348K.
  • Amgen made up 0.13% of Burleson & Co's portfolio in Q4 2022, its #99 holding.
  • Burleson & Co first reported a position in Amgen in Q3 2018 and has held it in 18 quarters since.
  • Burleson & Co's Amgen position peaked at $7.87M in Q2 2020.
  • 2,502 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.